The evolution of pain relief from opium to modern medicine

Opium dulled agony for Sumerian plowmen and Victorian surgeons. Painkillers always came with a promise: freedom from pain, shadowed by the threat of harm. Every age started out hopeful, then wound up in trouble: ancient Mesopotamian poppy fields, 19th-century laudanum bottles, morphine syringes handed to soldiers.
Painkillers, initially natural and later synthetic, kept medicine and society in flux. Each advance sparked new concerns: addiction, lethal error, and government crackdowns.
Pain, notoriously difficult to measure, drove societies to invent, extract, and refine ever-stronger remedies. In every era, painkillers marked the thin line between cure and catastrophe.

What are painkillers and how are they classified?

Painkillers – or analgesics – ease pain without knocking people out. They disrupt pain signaling by dampening neural transmission or quelling inflammation.
Opioids – both plant-derived and synthetic – attach to mu, kappa, and delta receptors in nerves, blocking pain from breaking through.
Non-opioid analgesics like acetaminophen and NSAIDs cut pain by halting prostaglandin production or lowering sensitivity in the brain, sidestepping opioid pathways entirely.

The World Health Organization’s 1986 three-step analgesic ladder sorted painkillers by strength:

• Step 1 – mild pain: non-opioids.
• Step 2 – moderate pain: weak opioids.
• Step 3 – severe pain: strong opioids.

Painkillers are classified as opioid, non-opioid, or adjuvant, each defined by their potency.

Ancient origins of pain relief

Inside Egyptian temples around 1550 BCE, scribes inked 700 recipes for pain and fever into the Ebers Papyrus. Each mixed spells with herbs, resins, and ground poppy.
Mesopotamian tablets from 2600 BCE listed opium, mandrake, and henbane as everyday pain remedies – a pharmacy based on custom and ritual.
Greco-Roman doctors drew sticky latex from Papaver somniferum and gave it for surgery or childbirth. In the Andes, healers chewed coca leaves to deaden wounds and quiet suffering.

Ancient pain relief relied on magical rites and uncertain dosages, but opium established the first enduring medical tradition.

That same poppy latex that eased ancient aches became the root of centuries of addiction.

A modern review traced how inhaled anesthesia – ether and chloroform – emerged not for daily pain but to erase sensation during surgery.

Opium, ether, and chloroform marked turning points as pain control shifted from ritual to chemistry.

What was the first painkiller in history?

Willow bark – rich in salicin – soothed pain and fever from Sumer to Egypt for 4,000 years before chemists finally isolated its key ingredient.
Paracelsus invented laudanum in 1527 by dissolving opium in alcohol. That became the first oral opiate medicine of Renaissance Europe.

The late 1800s brought lab-made painkillers: Ludwig Knorr created phenazone (antipyrine) in 1883, and Bayer released phenacetin in 1887 as one of the first mass-market analgesics.
From tree bark to chemical factories, the search for more reliable pain management continued without pause.

Where did painkillers originate?

Painkillers started in ancient Mesopotamia, Egypt, and South America, but Europe industrialized their production.
Pierre-Jean Robiquet separated codeine from opium in France, 1832, making a weaker but safer opioid.
C.R. Alder Wright made diamorphine (heroin) in 1874 at St. Mary’s Hospital in the UK, pushing pain medicine from plant to pure chemistry.

Meperidine (Demerol), patented in 1937, was the first fully synthetic opioid made for medicine.
Methadone, created in pre-WWII Germany and launched in the US in the 1940s, took painkillers beyond the poppy entirely.

Britain, France, and Germany each contributed breakthroughs that shaped pain relief in the chemical age.

How painkillers evolved in modern medicine?

In the 1800s, European chemists targeted pain at the molecular level, transforming folk remedies into pharmaceuticals.
Friedrich Sertürner pulled morphine out of opium in 1803, allowing for accurate dosing and injection – hospitals replaced tinctures with syringes.

Aspirin entered medicine after Felix Hoffmann made pure acetylsalicylic acid at Bayer in 1897. The Aspirin trademark followed two years later.
Acetaminophen, found in 1878, sat on the shelf for seventy years before McNeil Laboratories earned the FDA’s green light for Tylenol Elixir for Children in 1955 – then sales soared.

Aspirin’s 1897 breakthrough turned a home remedy into a drugstore staple – and into a heart attack shield.

Stewart Adams, with Boots in the 1960s, came up with ibuprofen as a safer anti-inflammatory option than aspirin. It hit UK pharmacies in 1969, landed in the US by 1974.
Opioid antidote therapy picked up in 1961, when Jack Fishman and Mozes Lewenstein made naloxone. By 1971, naloxone was reversing overdoses in emergency rooms.

Bayer’s heroin, first sold as a non-addictive morphine substitute, showed its true addictive bite within a decade – forcing regulators to realize that new molecules could be just as dangerous.

Tracing painkiller milestones-morphine (1803), acetylsalicylic acid (1897), acetaminophen (1955), ibuprofen (1969), naloxone (1971)-shows the transition from plant-based remedies to precision pharmaceuticals.

• Aspirin – scalable, anti-inflammatory, and protective for the heart.
• Acetaminophen – a fever and pain reliever with a unique safety record.
• Ibuprofen – tackled inflammation with fewer stomach risks than aspirin.
• Naloxone – changed emergency medicine by stopping opioid overdoses fast.

Historical risks, controversies, and regulatory challenges

New York’s Lower East Side, 1914: the Harrison Narcotic Act upended pain management. Doctors faced federal audits, taxes, prosecution.
The Federal Bureau of Narcotics, created in 1930, clamped down further. Opiate prescriptions went underground, fueling new black markets.

By 1970, the Controlled Substances Act locked morphine, oxycodone, and heroin into Schedule II or I – right alongside LSD and cannabis. The DEA gained full tracking power over every prescription.

James Campbell’s 1995 speech reframed pain as the “fifth vital sign.” Hospitals now measured pain with the same urgency as pulse.

The Veteran’s Health Administration rolled out mandatory pain checks in 1999; by 2001, every accredited U.S. hospital had to measure pain.
All this overlapped with Purdue Pharma’s high-octane push for OxyContin – prescriptions leaped from 670,000 in 1997 to 6.2 million by 2002.

One short 1980 New England Journal of Medicine letter, claiming addiction was rare, stoked prescriber confidence – despite no real long-term evidence.

Opiate scripts soared. So did addiction, drug diversion, and fatal overdoses. By 2021, U.S. opioid overdose deaths topped 100,000 a year – illicit fentanyl drove most of those fatalities.
In 2007, Purdue Pharma pleaded guilty to federal misbranding and paid $634.5 million. The cost to society dwarfed that payout.

A single misleading letter helped launch the opioid crisis, which killed over 100,000 Americans each year.

Rules, clinical guidelines, and pharma marketing kept colliding – cycles of liberalization, crackdown, crisis repeated again and again.

Comparing painkillers across the ages

Fragmentation. Healers once chewed willow bark and poppy resin; modern pain doctors measure out micrograms of carfentanil or program nerve stimulators.
Painkillers now span advanced molecules and devices, but pain itself-blending physical and emotional signals-remains difficult to measure or treat with a universal approach.

For years, chronic pain was dismissed as malingering by doctors and the International Association for the Study of Pain, until the 1970s. This shift compelled medicine to recognize suffering as a distinct diagnosis.
The World Health Organization’s Cancer Pain ladder (1986) prescribed a stepwise plan – acetaminophen, NSAIDs, then opioids – while non-drug options stayed on the sidelines.

Carfentanil, a synthetic opioid made for large animal anesthesia, is 10,000 times stronger than morphine and 100 times more potent than fentanyl. Humans almost never see it legally, but its appearance in street drugs has caused deadly outbreaks.

Companies like Glaxo Wellcome poured resources into both opioid and non-opioid painkillers. Still, no drug has cracked the pain paradox: it’s subjective, always changing, and stubbornly hard to pin down.

No era found a single cure-each generation’s painkillers traded precision for new dangers. Pain continually evolved, always remaining elusive.